• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

New Century Healthcare Completed the Acquisition of Chengdu New Century’s Equity Interest and Strategically Invested in the Equity of Chiron Healthcare

Share:

August 19, 2018

A leading mid-to high-end pediatric medical service provider in China – New Century Healthcare Holding Co. Limited and its subsidiaries are pleased to announce, 1) the acquisition of equity interest of Chengdu New Century Women’s and Children’s Hospital Co., Ltd. has been completed ; 2) the Company strategically invested in the equity of Chiron Healthcare Holdings Limited in Hong Kong (“Chiron Healthcare”, together with its subsidiaries, collectively “Chiron Healthcare Group”).

The board of directors of the Company announces that the acquisition of 85.0% equity interest of Chengdu New Century for a cash consideration of RMB200.0 million has been completed, and Chengdu New Century also completed the alteration registration with the relevant administration of industry and commerce and obtained the new business license on August 10, 2018.

In addition, on August 4, 2018, NCH Marvel Investment Limited, a wholly-owned subsidiary of the Company, entered into the share subscription agreement and other investment documents with Chiron Healthcare to subscribe the shares of Chiron Healthcare (the “Investment”). The Investment has been recently completed. Upon completion, the Group held 10.1% equity interests in Chiron Healthcare.

Chiron Healthcare Group is one of the major private specialized healthcare groups in Hong Kong, focusing on provision of holistic medium to high-end specialty healthcare services covering many departments including oncology, cardiology, general surgery, ear, nose & throat (otorhinolaryngology), orthopaedics and traumatology, obstetrics and gynecology, geriatrics, paediatrics, ophthalmology, urology and subfertility. Chiron Healthcare Group has a strong healthcare network made up of well-known specialist doctors, and operates a number of clinics in Hong Kong, including its large flagship clinics in Central and Tsim Sha Tsui. Chiron Healthcare Group has established in-depth cooperation with many famous private hospitals, major insurance companies and healthcare service platforms in Hong Kong. Apart from specialty outpatient and surgical services, Chiron Healthcare Group also provides healthcare management services including physical examination, physiotherapy and rehabilitation as well as vaccination for adults and children.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Mr. Jason Zhou, Chairman of New Century Healthcare commented, “Leveraging on our respective strengths in medical resources, network and management capability, the Group and Chiron Healthcare Group will carry out in-depth cooperation in many aspects, including but not limited to cross-border healthcare services (including oncology/specialty consultation, vaccination and medical services for women and children as well as assisted reproductive services, etc.), two-way referral services between Mainland China and Hong Kong, knowledge sharing in medical technology and trainings and medical institution management. We look forward to achieving synergies by complementing each other’s advantages and improving the quality of our healthcare services. Moreover, the strategic investment in and cooperation with Chiron Healthcare Group are in line with the business development strategy and plan of the Group, that is to enhance the healthcare network presence of the Group in the Guangdong-Hong Kong-Macao Greater Bay Area, expand the coverage of specialty healthcare services for women and children, and further expand and extend the New Century brand in the Greater China Region.”

Date: August 20, 2018

Source: The Pharma Time

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Allscripts, Microsoft partner on cloud-driven clinical trials modelAllscripts, Microsoft partner on cloud-driven clinical trials model
  • Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.
  • CONMED Completes Acquisition of Buffalo Filter LLCCONMED Completes Acquisition of Buffalo Filter LLC
  • Fortress Biotech Announces Receipt of Notice of Option Exercise from AstraZeneca to Fully Acquire Caelum Biosciences, A Company Founded By Fortress BiotechFortress Biotech Announces Receipt of Notice of Option Exercise from AstraZeneca to Fully Acquire Caelum Biosciences, A Company Founded By Fortress Biotech
  • Biotech Conagen Acquires Production Platform Of Therapeutic ProteinsBiotech Conagen Acquires Production Platform Of Therapeutic Proteins
  • Acquisition in Canada’s Healthcare Sector – Logibec Announces the Acquisition of Knowlegde4You CorporationAcquisition in Canada’s Healthcare Sector – Logibec Announces the Acquisition of Knowlegde4You Corporation
  • Mid-Atlantic Dental Partners to Acquire Birner Dental Management Services, Inc.Mid-Atlantic Dental Partners to Acquire Birner Dental Management Services, Inc.
  • Mymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple SclerosisMymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple Sclerosis

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications